Member Info for Magsy18

Croz, GDR have non-covid related products progressing well too. Even if covid does only provide a spike in revenue for the short to medium term, reinvesting that capital back into the business should yield some long term benefits no?

The company is still worth less than £100m, I would be almost certain there is profit to be had from here in the future.

Not at all, I committed to this share a couple of weeks ago and don’t intend to trade it.

Apologies if my observations of your poor predictive ability offended you.

That’s the great thing about shares, whether the price goes up or down its good news. If it goes up then obviously it’s great but if it goes down: -

- it’s a top up opportunity.
- it’s a tree shake to trigger those stop losses
- the MMs just want your shares so they can sell for higher later.

There is no other reason why share prices drop, fortunately for us.

I never understand the mentality of people who continue to make predictions when their track record is so poor.

TLW should be in the 30’s by now Sharebel?

You get some great news and then because the ridiculous expectations of the morons aren’t met, the negativity starts.

This is a great stepping stone but approvals don’t pay the bills, sales do.

Am looking forward to it being above £2 by 10:30 sharebel as per your earlier statement.

Punit, the people who sold on the spike can buy back now and have 5-10% more shares than they did yesterday.

Can you explain why these people should be kicking themselves?

Andy you said they SNG would go stellar too. What happened there?

This will never ever hit £3 today. If it stabilises around £2.20 then I will be happy.

Samolly why are you surprised? You ramp with unrealistic claims which subsequently do not get met. The only surprise is that you continue to embarrass yourself with the nonsense that you post.

Samolly, when can we expect the 250000 a day NHS contract news that you were ramping about yesterday?

Will be interesting to see how it performs compared to NCYT on their product launch. Based on their market cap at the time and taking into account the placing shares that would make the GDR share price £2.50.

Why does this OptiGene test mean the rise of GDR within the NHS?

You are suggesting that investors look only at the share price and not the market cap when deciding to invest, which may be true for complete amateurs but is not going to be the case for seasoned PIs.

If you would have suggested that less shares in issue means that on average there is likely to be less liquidity in terms of shares then you may have had a point.

Out of interest Nickel_Investor, when isn’t the buyer forced to pay higher?

And then ‘for balance’ GDR has been as high as £100m.

NCYT has contracts for £90m worth of tests and their market cap is currently sitting at around 220m.

Samolly2 is definitely one of the fantasists to be ignored, glad you called him out! There is so much potential positivity to come for GDR, £4 does indeed seem realistic if all goes well but I will remain cautious until then!

3 weeks for CE marking is quite aggressive. It’s not about giving a definitive timescale it’s about setting realistic expectations especially if it’s something out of your control.

Under promise and over deliver.

And there it is.

So clearly I think there is profit to be made here but because I am not convinced that it will increase by 70% or so in a week, you have an issue with it?

Pathetic and weak. Investing isn’t for you if you can’t deal with opinions that don’t match your own.